Expandable bone grafts and methods of manufacture thereof
The present invention relates to compressed bone-based products and methods to make the same. The maintained compressed state of the product serves to enhance the product's inherent osteoconductivity.
1. A bone-based product adapted to fit within a void, wherein when the bone-based product comprises entangled bone fibers, and is within the void, the bone-based product exerts an active expansion pressure on a surface of the void of about 1 MPa a to about 10 MPa, wherein the bone-based product is a body, wherein the bone-based product comprises a void to bone ratio of between about 1:99 and about 1:11, and wherein the bone fibers are entangled such that at least one property of shape retention, cohesive, pliability and compression state are maintained for a period of between about 10 minutes and about 1 year upon rehydration.
2. The bone-based product of claim 1 , wherein the void is contained within a medical apparatus.
3. The bone-based product of claim 2 , wherein the medical apparatus is a medical implant.
4. The bone-based product of claim 1 , wherein the product further comprises a material selected from the group consisting of bone chips, bone particles, bone chunks, bone sponge, and combinations thereof.
5. The bone-based product of claim 1 , wherein the bone-based product is produced from cortical bone, cancellous bone and combinations thereof.
6. The bone-based product of claim 1 , wherein the bone-based product is produced from at least one of a fully demineralized bone, a partially demineralized bone, a mineralized bone, and combinations thereof.
7. The bone-based product of claim 1 , wherein the bone-based product is at least one of a partially dehydrated, a fully dehydrated, or a fully hydrated.
8. The bone-based product of claim 1 , wherein the product is dehydrated and when it is rehydrated, expands to about 50% to about 99% of a pre-dehydrated state.
9. The bone-based product of claim 1 , wherein the bone-based product is osteoinductive.
10. The bone-based product of claim 1 , wherein the bone-based product consists of a bone.
11. The bone-based product of claim 1 , wherein a residual moisture content of the bone-based product is less than about 6%.
12. The bone-based product of claim 1 , further comprising a coating, wherein the coating is an antibacterial coating, and wherein a material of the antibacterial coating is one of an antifolate, an aminoglycoside, a carbapenem, a cephalosporin, a fluoroquinoline, a glycopeptide, a macrolide, a monobactam, an oxazolidone, a penicillin, a rifamin, a sulfonamide, a tetracycline, or combinations thereof.
13. An implantable medical device, comprising:
a structure comprising a void; and
a bone-based product comprising entangled bone fibers, wherein the bone-based product is adapted to fit within the void, wherein the bone-based product exerts an active expansion pressure on a surface of the void of about 1 MPa to about 10 MPa, wherein a material of the bone-based product consists of a bone, and wherein the bone fibers are entangled such that at least one property of shape retention, cohesive, pliability and compression state are maintained for a period of between about 10 minutes and about 1 year upon rehydration.
14. The implantable medical device of claim 13 , wherein the bone is selected from the group consisting of cortical bone, cancellous bone, and combinations thereof.
15. The implantable medical device of claim 13 , wherein the structure is a surgical implant.
16. The implantable medical device of claim 13 , wherein the bone is fully demineralized bone.
17. The implantable medical device of claim 13 , wherein the bone-based product further comprises a material selected from the group consisting of bone chips, bone particles, bone chunks, bone sponge, and combinations thereof.
18. The implantable medical device of claim 13 , wherein a material of the structure is at least one of a bone, a ceramic, a metal, a plastic, or a biodegradable polymer.
19. The implantable medical device of claim 13 , wherein the bone-based product comprises a void to bone ratio of between about 1:99 and about 1:11.
20. The implantable medical device of claim 13 , further comprising a coating, wherein the coating is an antibacterial coating, and wherein a material of the antibacterial coating is one of an antifolate, an aminoglycoside, a carbapenem, a cephalosporin, a fluoroquinoline, a glycopeptide, a macrolide, a monobactam, an oxazolidone, a penicillin, a rifamin, a sulfonamide, a tetracycline, or combinations thereof.